Vicore Pharma Holding AB (publ) financial reports, Vicore Pharma Holding AB (publ) annual revenue in 2024. When does Vicore Pharma Holding AB (publ) report revenue?
Vicore Pharma Holding AB (publ) total revenue, net income and dynamics of changes in Swedish krona today
Vicore Pharma Holding AB (publ) current income and income for the latest reporting periods. Vicore Pharma Holding AB (publ) net revenue for today is 0 kr. The dynamics of Vicore Pharma Holding AB (publ) net income went up. The change was 10 165 000 kr. Chart of online financial report of Vicore Pharma Holding AB (publ). The financial schedule of Vicore Pharma Holding AB (publ) consists of three charts of the main financial indicators of the company: total assets, net revenue, net income. The value of Vicore Pharma Holding AB (publ) assets on the online chart is displayed in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
0 kr
-100 % ↓
-48 106 000 kr
-
31/12/2020
0 kr
-
-58 271 000 kr
-
30/09/2020
0 kr
-
-35 995 000 kr
-
30/06/2020
0 kr
-100 % ↓
-24 222 000 kr
-
31/12/2019
0 kr
-
-27 577 000 kr
-
30/09/2019
-10 000 kr
-
-22 894 000 kr
-
30/06/2019
2 000 kr
-
-26 569 000 kr
-
31/03/2019
30 000 kr
-
-16 044 000 kr
-
Show:
to
Vicore Pharma Holding AB (publ) financial report charts
The latest dates of Vicore Pharma Holding AB (publ) financial statements available online: 31/03/2019, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The current date of the financial report of Vicore Pharma Holding AB (publ) for today is 31/03/2021. Operating income Vicore Pharma Holding AB (publ) is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Vicore Pharma Holding AB (publ) is -46 824 000 kr
Vicore Pharma Holding AB (publ) quarterly report dates
Net income Vicore Pharma Holding AB (publ) is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Vicore Pharma Holding AB (publ) is -48 106 000 kr Current assets Vicore Pharma Holding AB (publ) is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Vicore Pharma Holding AB (publ) is 596 670 000 kr Total assets Vicore Pharma Holding AB (publ) refers to the total amount of assets owned by a person or entity. Total assets Vicore Pharma Holding AB (publ) is 673 620 000 kr
Current cash Vicore Pharma Holding AB (publ) - the sum of all of the cash a company has on the date of report. Current cash Vicore Pharma Holding AB (publ) is 442 663 000 kr
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-
-
-
-
-
-3 973 000 kr
-4 437 000 kr
-5 300 000 kr
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
-
-
-
-
-
3 973 000 kr
4 439 000 kr
5 330 000 kr
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
-
-
-
-
-
-10 000 kr
2 000 kr
30 000 kr
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-10 000 kr
2 000 kr
30 000 kr
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-46 824 000 kr
-57 810 000 kr
-38 742 000 kr
-27 473 000 kr
-30 220 000 kr
-22 834 000 kr
-24 839 000 kr
-16 097 000 kr
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-48 106 000 kr
-58 271 000 kr
-35 995 000 kr
-24 222 000 kr
-27 577 000 kr
-22 894 000 kr
-26 569 000 kr
-16 044 000 kr
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
42 300 000 kr
53 706 000 kr
34 530 000 kr
29 701 000 kr
23 535 000 kr
13 230 000 kr
14 577 000 kr
5 591 000 kr
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
46 824 000 kr
57 810 000 kr
38 742 000 kr
27 473 000 kr
30 220 000 kr
22 834 000 kr
24 841 000 kr
16 127 000 kr
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
596 670 000 kr
327 847 000 kr
366 703 000 kr
215 214 000 kr
266 515 000 kr
175 704 000 kr
195 259 000 kr
218 172 000 kr
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
673 620 000 kr
406 515 000 kr
440 047 000 kr
291 168 000 kr
341 108 000 kr
248 465 000 kr
268 759 000 kr
293 140 000 kr
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
442 663 000 kr
248 618 000 kr
213 780 000 kr
134 975 000 kr
187 586 000 kr
172 197 000 kr
193 491 000 kr
215 971 000 kr
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
16 954 000 kr
14 480 000 kr
11 880 000 kr
11 003 000 kr
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
19 511 000 kr
17 205 000 kr
15 046 000 kr
13 392 000 kr
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
5.72 %
6.92 %
5.60 %
4.57 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
629 149 000 kr
354 513 000 kr
411 993 000 kr
272 732 000 kr
321 597 000 kr
231 260 000 kr
253 713 000 kr
279 748 000 kr
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-24 802 000 kr
-21 253 000 kr
-22 440 000 kr
-18 505 000 kr
Last revenue report of Vicore Pharma Holding AB (publ) was 31/03/2021. According to last financial report total revenue in Vicore Pharma Holding AB (publ) was 0 Swedish krona and changed by -100% since last year. Net income in Vicore Pharma Holding AB (publ) was -48 106 000 kr in last quartal, net income changes to 0%.
